Research on drug creation and development is crucial for chemical scientists and pharmaceutical businesses. However, there are obstacles and difficulties that affect medication design and development, such as low effectiveness, off-target delivery, time consumption, and excessive cost. Big and complicated data from clinical trials, proteomics, microarray, and genomes all represent a challenge to the drug discovery process. Drug research and discovery heavily rely on artificial intelligence and machine learning technologies. Stated differently, the field has been brought up to date by deep learning algorithms and artificial neural networks. Numerous drug discovery processes, including peptide synthesis, ligand- and structure-based virtual screening, toxicity prediction, drug monitoring and release, pharmacophore modeling, quantitative structureâ€“activity relationship, drug repositioning, polypharmacology, and physiochemical activity, have made use of machine learning and deep learning algorithms. Historical data supports the use of deep learning and artificial intelligence in this domain. Furthermore, newly created modeling algorithms received crucial help from innovative data mining, curation, and management strategies. In conclusion, developments in deep learning and artificial intelligence present a great chance for a methodical approach to medication discovery and design that will ultimately benefit humanity. 